UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

December 17, 2007

Date of report (Date of earliest event reported)

 

Cyanotech Corporation

(Exact name of registrant as specified in its charter)

 

NEVADA

 

000-14602

 

91-1206026

(State or other jurisdiction of

 

(Commission File Number)

 

(IRS Employer Identification

incorporation)

 

 

 

Number)

 

73-4460 Queen Kaahumanu Highway, Suite #102, Kailua Kona, HI 96740

(Address of principal executive offices)

 

(808) 326-1353

(Registrant’s telephone number)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 8.01 — Other Events

 

Cyanotech has experienced a severe interruption in Spirulina production caused by dilution and overflow from recent torrential rains during a period when the company was re-inoculating its Spirulina ponds to improve yield.  The facility experienced an unprecedented seven inches of rain in three days.  With the rains subsiding, the company has taken aggressive action to complete re-inoculation, correct dilution and overflow problems, and restore production.  The company expects to be back in full Spirulina production in January 2008.

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CYANOTECH

 

 

CORPORATION (Registrant)

 

 

 

 

 

December 17, 2007

By:

/s/ William R. Maris

 

 

William R. Maris
Chief Financial Officer
and VP of Finance and
Administration

 

 

2